Hepalys Pharma Overview
- Year Founded
-
2021
- Status
-
Private
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$1.85M
- Investors
-
6
Hepalys Pharma General Information
Description
Developer of therapeutic drugs designed for the treatment of non-alcoholic steatohepatitis. The company is developing a licensed drug candidate that has shown effectiveness in eliminating the condition and enhancing fibrosis, enabling patients to access a new treatment option for a critical medical condition.
Contact Information
Website
www.hepalys.comCorporate Office
- 3-11, Nihonbashi-honcho2-chome
- Chuo-ku
- Tokyo, Chuo-ku 103-0023
- Japan
Corporate Office
- 3-11, Nihonbashi-honcho2-chome
- Chuo-ku
- Tokyo, Chuo-ku 103-0023
- Japan
Hepalys Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Seed Round | 11-Oct-2023 | $1.85M | Completed | Clinical Trials - Phase 2 | ||
| 1. Accelerator/Incubator | Completed | Startup |
Hepalys Pharma Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Class A Preferred |
Hepalys Pharma Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Catalys Pacific | Venture Capital | Minority | ||
| DBJ Capital | Corporate Venture Capital | Minority | ||
| Medipal Innovation | Corporate Venture Capital | Minority | ||
| Mitsubishi UFJ Capital | Venture Capital | Minority | ||
| Nippon Venture Capital | Corporate Venture Capital | Minority |
Hepalys Pharma FAQs
-
When was Hepalys Pharma founded?
Hepalys Pharma was founded in 2021.
-
Where is Hepalys Pharma headquartered?
Hepalys Pharma is headquartered in Tokyo, Japan.
-
What industry is Hepalys Pharma in?
Hepalys Pharma’s primary industry is Drug Discovery.
-
Is Hepalys Pharma a private or public company?
Hepalys Pharma is a Private company.
-
What is the current valuation of Hepalys Pharma?
The current valuation of Hepalys Pharma is .
-
What is Hepalys Pharma’s current revenue?
The current revenue for Hepalys Pharma is .
-
How much funding has Hepalys Pharma raised over time?
Hepalys Pharma has raised $1.85M.
-
Who are Hepalys Pharma’s investors?
Catalys Pacific, DBJ Capital, Medipal Innovation, Mitsubishi UFJ Capital, and Nippon Venture Capital are 5 of 6 investors who have invested in Hepalys Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process